Ana B. Custodio - Publications

Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.

Journal: Journal of clinical medicine

Published: May 11, 2026

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Journal: Investigational new drugs

Published: March 12, 2026

Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 20, 2026

SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 09, 2026

Proximal-To-Distal Gradient and Its Implications in Differentiation and Prognosis in Colorectal Neuroendocrine Neoplasms: The RGETNE-HERACLES Study.

Journal: Neuroendocrinology

Published: January 21, 2026

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Journal: The oncologist

Published: January 19, 2026

A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study.

Journal: Frontiers in nutrition

Published: January 19, 2026

Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.

Journal: British journal of cancer

Published: June 25, 2025

DPYD-guided fluoropyrimidine dose adjustment in colorectal cancer DPYD carriers: start slower to finish stronger.

Journal: Frontiers in pharmacology

Published: June 11, 2025

Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 06, 2025

Novel therapies targeting delta-like ligand 3 (DLL3) in pulmonary and gastroenteropancreatic neuroendocrine carcinomas.

Journal: Cancer treatment reviews

Published: May 26, 2025

Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.

Journal: International journal of molecular sciences

Published: September 11, 2024